Exome-based Preconception Carrier Screening for the Mexican Jewish Community; Yields and Implications
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Introduction
Preconception carrier screening (PCS) reduces monogenic disease incidence, exemplified by a 90% decline in Tay-Sachs among Ashkenazi populations. The Mexican Jewish Community (MJC), an endogamous population, may have increased prevalence of population-specific genetic disorders. The added value of exome sequencing (ES) over standard panels remains unclear.
Objectives
To identify pathogenic/likely pathogenic (P/LP) variants in autosomal recessive (AR), X-linked (XL), and mitochondrial genes, evaluate secondary findings (SF), and define population-specific allele frequencies in the MJC.
Methods
From 2020-2025, 787 couples (1,574 individuals) underwent ES following counseling and consent. Genetic data was analyzed including SNVs, CNVs, and mitochondrial DNA. Reporting was limited to P/LP variants and SF.
Results
Shared AR carrier status was identified in 49 couples (6.2%): 18.4% associated with severe, 16.3% moderate, and 65.3% with mild conditions. In 71.4% of couples, both partners carried the same variant, consistent with endogamy within the cohort. Maternal findings were identified in 10 women (1.27%). Clinically actionable SF were found in 2.85% of individuals. ES identified 12 at-risk couples (24.4%), undetected by standard panels. Individual genomic profiling revealed 920 rare P/LP variants, including 146 novel alleles, underscoring the distinct genetic architecture of the MJC.
Conclusion
ES-based PCS improves detection of at-risk couples beyond conventional screening and supports its use in endogamous populations.
